Diabetes, Digestive, and Kidney Diseases Extramural Research in Kansas
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $42.6 million to recipients in Kansas in 45 grants from fiscal 2021 to 2025, 0.4% of the program's national total. University of Kansas Medical Center Research Institute, Inc. received the most, $41.2 million.
- Awarded in Kansas$42.6 million
- Awards45
- Share of the program0.4%
- Rank among states32nd of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 27 | $10.2 million |
| FY 2022 | 24 | $9.1 million |
| FY 2023 | 22 | $9.1 million |
| FY 2024 | 17 | $6.5 million |
| FY 2025 | 18 | $7.8 million |
Recipients in Kansas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Kansas Medical Center Research Institute, Inc. | Other | 43 | $41.2 million |
| University of Kansas Center for Research Inc | Other | 1 | $1.1 million |
| Flowpoint Medical Inc | Small businesses | 1 | $379,836 |
Open opportunities under this program
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
See all 68 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Kansas?
$42.6 million from fiscal 2021 to 2025, across 45 awards. Kansas ranks 32nd of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Kansas?
The largest recipient is University of Kansas Medical Center Research Institute, Inc., with $41.2 million in 43 awards. Next are University of Kansas Center for Research Inc and Flowpoint Medical Inc.
Can organizations in Kansas apply now?
Yes, 68 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Kansas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families